Table of Contents
Advertisement
ALMAG-01
CONTENTS
1. PURPOSE OF THE DEVICE ................................................................................................................................... 3
1.1 GENERAL INFORMATION ............................................................................................................................ 3
1.2 INDICATIONS FOR USE ................................................................................................................................ 3
1.3. CONTRAINDICATIONS ................................................................................................................................ 4
2. SPECIFICATIONS ................................................................................................................................................. 4
3. SET OF SUPPLY ................................................................................................................................................... 6
4. OPERATING PRINCIPLE OF THE DEVICE .............................................................................................................. 6
4.1 PHYSIOLOGICAL EFFECT OF PULSED ELECTROMAGNETIC FIELD ON THE HUMAN BODY ............................ 6
4.2 DEVICE DESCRIPTION .................................................................................................................................. 8
4.3 MARKING .................................................................................................................................................. 10
5. SAFETY INSTRUCTIONS .................................................................................................................................... 11
6. PREPARATION FOR USE ................................................................................................................................... 11
7. TREATMENT PROCEDURES............................................................................................................................... 13
7.1. MUSCULOSKELETAL SYSTEM DISEASES .................................................................................................... 13
Osteochondrosis ........................................................................................................................................ 13
Deforming osteoarthritis ........................................................................................................................... 16
Humeroscapular periarthrosis ................................................................................................................... 17
Arthritis ...................................................................................................................................................... 19
Epicondylitis ............................................................................................................................................... 20
Gout ........................................................................................................................................................... 22
Bursitis ....................................................................................................................................................... 23
Myositis ..................................................................................................................................................... 24
Tenosynovitis ............................................................................................................................................. 25
7.2. INJURIES AND THEIR AFTER-EFFECTS ....................................................................................................... 26
Bone fractures ........................................................................................................................................... 26
Internal joint injury .................................................................................................................................... 27
Soft tissue bruises, hematoma, posttraumatic edema .............................................................................. 27
Ligament and muscle injuries .................................................................................................................... 28
Postoperative wounds ............................................................................................................................... 29
Sluggish purulent wounds, phlegmons, burns ........................................................................................... 29
7.3. DISEASES OF PERIPHERAL NERVOUS SYSTEM .......................................................................................... 30
Neuritis ...................................................................................................................................................... 30
Facial nerve neuritis ................................................................................................................................... 30
Radial nerve neuritis .................................................................................................................................. 31
Ulnar nerve neuritis ................................................................................................................................... 32
Operating Manual
Page 1
Advertisement
Table of Contents
Related Manuals for Elamed ALMAG-01
Summary of Contents for Elamed ALMAG-01
-
Page 1: Table Of Contents
ALMAG-01 CONTENTS 1. PURPOSE OF THE DEVICE ........................... 3 1.1 GENERAL INFORMATION ..........................3 1.2 INDICATIONS FOR USE ..........................3 1.3. CONTRAINDICATIONS ..........................4 2. SPECIFICATIONS ..............................4 3. SET OF SUPPLY ..............................6 4. OPERATING PRINCIPLE OF THE DEVICE ......................6 4.1 PHYSIOLOGICAL EFFECT OF PULSED ELECTROMAGNETIC FIELD ON THE HUMAN BODY ...... - Page 2 11. MANUFACTURER'S WARRANTY ........................44 Dear Customer! You have purchased ALMAG-01 Pulsed Electromagnetic Field (PEMF) Therapy Device (hereinafter referred to as ALMAG) intended for hospital use for treatment and prevention of a wide range of diseases, as well as for home use by patients upon doctor`s advice. In order to perform treatment, please follow the guidelines of this Manual.
-
Page 3: Purpose Of The Device
ALMAG-01 1. PURPOSE OF THE DEVICE 1.1 GENERAL INFORMATION 1.1.1 ALMAG has been designed for therapeutic treatment of the human body by means of pulsed electromagnetic field, to be performed either by medical staff at physiotherapy departments of healthcare facilities, or by individual patients at home. -
Page 4: Contraindications
ALMAG-01 - sluggish purulent wounds, phlegmons, burns Diseases of peripheral nervous system: - neuritis - facial nerve neuritis - radial nerve neuritis - ulnar nerve neuritis - median nerve neuritis - sciatic nerve (ischias) neuritis - peroneal nerve neuritis - plexitis... -
Page 5: Specifications
ALMAG-01 Inclusions of metal elements in bone tissues are not a contraindication for therapeutic usage of the device. 2. SPECIFICATIONS 2.1 AC power supply: ~230V (-34,5V; +23V), frequency 50Hz; ~120V (-10V; +6V), frequency 60Hz. 2.2 Power consumption: 35 VA. -
Page 6: Set Of Supply
+41°C 2.15 Class of the device according to MDD 93/42/EEC – Class IIa. 3. SET OF SUPPLY The complete delivery set includes: - "ALMAG-01" device; - Pulsed electromagnetic field (PEMF) indicator; - Operating Manual. 4. OPERATING PRINCIPLE OF THE DEVICE 4.1 PHYSIOLOGICAL EFFECT OF PULSED ELECTROMAGNETIC FIELD ON THE HUMAN... - Page 7 ALMAG-01 metabolism prevents disease progression and accelerates regeneration processes and recovery of the diseased cells. Application of low-frequency PEMF as a treatment procedure has a number of beneficial effects on a patient’s body: - a sedative effect caused by stimulation of nervous inhibition processes, which results in emotional stress relief and sleep normalisation;...
-
Page 8: Device Description
ALMAG-01 4.2 DEVICE DESCRIPTION ALMAG consists of: - a control unit (pulse generator) Emitter connected to four emitters; emitters connection cable; (2.1±0.1)m - power cable: (1.2±0.1)m. All connections of the individual units are flexible and non-detachable. Note: the first emitter is the only one connected to the control unit cable. - Page 9 ALMAG-01 Due to the high penetrating ability of ALMAG’s magnetic field, the treatment can as well be performed through clothing, dry or damp gauze bandage, or plaster bandage up to 1 cm thick. NOTE: To position the device on the body properly, please follow the instructions herein.
-
Page 10: Marking
ALMAG-01 4.3 MARKING The mark defines the device as complying to Class II in terms of electrical safety according to IEC 60601-1 Warnings on safety and efficacy of operation Emitters are protected with reinforced insulation Indicates necessity to refer to the Operational manual... -
Page 11: Safety Instructions
ALMAG-01 5. SAFETY INSTRUCTIONS 5.1 Please study this Operating Manual carefully before use. 5.2 Examine the device before use carefully. Make sure that all parts of the device are undamaged. 5.3 Place the control unit on a flat surface. Make sure the cable is not twisted or taut. - Page 12 ALMAG-01 While cleaning, avoid leakage of the disinfectant solution or detergent inside the control unit or the emitters. Use the PEMF indicator to check the presence of electromagnetic field on the emitters of the actuated device by applying the indicator onto the working side of the emitters (marked with “N”...
-
Page 13: Treatment Procedures
ALMAG-01 Do not use PEMF therapy after taking alcohol. 7. TREATMENT PROCEDURES 7.1. MUSCULOSKELETAL SYSTEM DISEASES Osteochondrosis Osteochondrosis is a degenerative dystrophic disease characterized by deterioration of intervertebral disks and connective tissues of the backbone and the nervous system. Intervertebral disks lose their cushioning ability, which results in compression and deformation of a nerve root, a vessel, or the spinal cord, and causes pain. - Page 14 ALMAG-01 Osteochondrosis of the thoracic spine induces spinal pains, a pain syndrome in various body organs (heart, stomach, lungs, liver, kidneys, urinary bladder, pancreas) and dyskinesia, a disorder of the movement function of these organs. Very often osteochondrosis has neurological complications as a result of nerve ending compression.
- Page 15 ALMAG-01 Fig. 2 Fig. 4 Fig. 3 ALMAG is effective for acute osteochondrosis complicated with neuritis, but the procedures are taken once a day in this case. Treatment begins with the diseased region of the spine (cervical or lumbar), followed by device application to the areas along the affected nerves: - sciatic, tibial, fibular (see Fig.
-
Page 16: Deforming Osteoarthritis
ALMAG-01 minimum (10 min) duration. If blood pressure does not lower down or the undesirable symptoms remain, stop the treatment and consult with attending physician. Deforming osteoarthritis Deforming osteoarthritis is a dystrophic disease of joints characterized by degeneration of articulate cartilages and periarticular tissues. -
Page 17: Humeroscapular Periarthrosis
ALMAG-01 be placed on the lateral joint projection, and the 1 one on the front projection (see Fig. The first 6 days the treatment is to be carried 2-3 times a day for 8 min. Make a pause for 1 day and continue treatment for 6 days (procedure duration is 10 minutes, twice a Fig. - Page 18 ALMAG-01 Typical symptoms Shoulder pain during movement which increases at night time, dextrality of affection (right side for right-handers), tenderness at thumb pressure. Patient suffering from humeroscapular periarthrosis should limit the load on the diseased joint and do physical exercise regularly, also immediately after completion of a PEMF course.
-
Page 19: Arthritis
ALMAG-01 Attention! It is essential to check blood pressure before the procedure and in 15 minutes after it during the first 3 days of treatment. In case blood pressure increases (by 10-15 mm Hg) do not stop the treatment, but make the treatment procedures and the treatment course 2 times shorter. -
Page 20: Epicondylitis
ALMAG-01 on Fig. 5. Procedures are to be carried out twice a day. The emitters’ position for treatment of elbow joint arthritis is shown on Fig. 9. Treatment procedure is the same as for deforming osteoarthritis. Epicondylitis Epicondylitis is an inflammation of tendon tissues in the place of their attachment to a bone. - Page 21 ALMAG-01 The treatment process for epicondylitis of an elbow joint tendon complicated with elbow nerve neuritis is as follows: 1) The patient lies on his/her back; 2) ALMAG is placed parallel to the body; 3) The patient puts his affected hand with palm up along the body;...
-
Page 22: Gout
ALMAG-01 repeated treatment course, if required, can be performed in 2 months. For repeated courses of treatment procedure duration is 15-20 min., the course length is 20 days without breaks. Gout The gout is a variety of rheumatic joint disease caused by deposition of uric acid salts (urates). -
Page 23: Bursitis
ALMAG-01 second one. For repeated courses the procedures are carried out once a day for 15-20 minutes. The total length of the repeated course is 20 days without breaks. Bursitis Bursitis is the inflammation of the periarticular bursa of a joint. It arises as a result of joint trauma, excess physical activity, or as an aftereffect of arthritis and some other infectious diseases. -
Page 24: Myositis
ALMAG-01 two joints. After the course completion, it is necessary to have a 10-day break before starting treatment of other joints or a different disease. Another technique of treatment may be used for adjacent joints (for example, a shoulder and an elbow joint). In this case the chain of emitters is placed along the arm, with the ends embracing both joints. -
Page 25: Tenosynovitis
ALMAG-01 processes. The procedures are prescribed as part of combined therapy with external anti-inflammatory medications. Treatment procedure The emitters of ALMAG are placed along the affected muscles of the back, abdomen, arms or legs. If the body muscles are affected, the emitters are placed on a couch, and the patient lies down onto them so that they are spread along the affected zone. -
Page 26: Injuries And Their After-Effects
ALMAG-01 7.2. INJURIES AND THEIR AFTER-EFFECTS Bone fractures A fracture is an infringement of the integrity of bone tissue structure. Fractures can be closed, open, with displacement and without it. A fracture is usually accompanied by intensive pain and fracture area deformation, as well as edema of the surrounding tissue. -
Page 27: Internal Joint Injury
ALMAG-01 ALMAG can be used to perform short-term courses for treatment of the pain syndrome appearing in the area of the healed fracture during periods of weather change or after exposure to cold. Such treatment course consists of 7-8 procedures. The procedure duration is 15-20 minutes. -
Page 28: Ligament And Muscle Injuries
ALMAG-01 Treatment procedure The procedure duration is 10-15 minutes twice a day. The emitters are placed along or around the lesion focus. In case of a trivial (smaller) trauma, the treatment course can be limited to 6-12 procedures. Ligament and muscle injuries... -
Page 29: Postoperative Wounds
ALMAG-01 Postoperative wounds Therapeutic effect Therapeutic effect of PEMF on the wounded surface entails reduction of the wound healing period, with formation of a fine flexible scar. The application of the device after a surgery prevents development of different complications and reduces the probability of herniation (in case of abdominal surgeries). -
Page 30: Diseases Of Peripheral Nervous System
ALMAG-01 The emitters are placed over a wet or dry gauze bandage along or around the affected area (after wound cleaning). Procedure duration is 10-15 minutes once a day. The treatment course length, depending on the burn degree, is 10-18 days. It is recommended to repeat PEMF therapy with ALMAG, especially in severe cases, in 30-40 days: this minimises the cosmetic defects after a wound or burn. -
Page 31: Radial Nerve Neuritis
ALMAG-01 Amplification of the anti-inflammatory effect of complex therapy, activation of blood circulation and lymph outflow in the facial area, improvement of the facial nerve conduction, restoration of the mimic muscles’ function, prevention of formation of muscle contracture (permanent mobility restriction). -
Page 32: Ulnar Nerve Neuritis
ALMAG-01 Ulnar nerve neuritis Ulnar nerve neuritis is caused by injuries of elbow joint or infection. The aim of PEMF by ALMAG in this case is the same as for radial nerve neuritis. The device is placed in such a way that the first emitter is on the area closest to the vertebral column and the last one on the area farthest from it. -
Page 33: Peroneal Nerve Neuritis
ALMAG-01 Peroneal nerve neuritis Peroneal nerve neuritis may occur following a trauma or different infections and intoxications. Therapeutic effect Exposure of the peroneal nerve innervation area to PEMF produces a soothing, anti-edematous, and anti-inflammatory effect; relieves the vascular and muscular spasm; normalises blood circulation, tone, and metabolism in the tissue of the innervated muscles. -
Page 34: Neuralgia
ALMAG-01 clavicle and the shoulder joint. The 3rd and the 4th should be put along the inner side of the arm affected by paresis (Fig. 17). Treatment procedure for lumbosacral plexitis The procedure is the same as for osteochondrosis. 7.4. NEURALGIA Neuralgia is a burning and shooting pain occurring along the nerve trunk and its branches and located in the area of certain nerves or nerve roots. -
Page 35: Occipital Neuralgia
ALMAG-01 anti-inflammatory and vasodilating action. Application of the device as part of complex treatment of trigeminal neuralgia combined with appropriate medication considerably increases the medical effect. Treatment procedure The first emitter is placed on the affected part of the face covering the cheeks and the base of the lower jaw bone. -
Page 36: Traumas Of Central Nervous System
ALMAG-01 7.5. TRAUMAS OF CENTRAL NERVOUS SYSTEM Vertebral column and spinal cord traumas Traumas of the vertebral column and spinal cord are very dangerous, as they may lead to functional disorders of many organs and body systems, and even to a paralysis. Spinal nerve endings (roots) innervating different body organs are located on the spinal cord. -
Page 37: Pancreatic Diabetes Complications
ALMAG-01 start traumatizing the nerve roots and clamping the blood vessels. The disease progression leads to an onset of ischemic (insufficient blood supply) zones in different regions of the backbone. In the cervical spine, osteophytes (bone spurs) are formed, resulting in a chronic disorder of spinal circulation (myelopathy). -
Page 38: Diabetic Polyneuropathy
ALMAG-01 Treatment procedure When shin vessels are affected with diabetic angiopathy, the shin (lower leg) is wrapped with ALMAG covering the back of the foot (see Fig. 21). IMPORTANT! The first emitter is placed closest to the knee, the last one to the foot. -
Page 39: Diseases Of The Venous System Of The Upper And Lower Limbs
ALMAG-01 - severe pains in the lower legs in the state of rest at night time. ALMAG is applied as part of complex therapy aimed primarily at the underlying disease. Exposure to the magnetic field results in improved conduction of nervous impulses along the nerve fibers that stimulates recovery of the functions of the affected peripheral nerve endings. -
Page 40: Chronic Thrombophlebitis At A Stage Of Trophic Disorders
ALMAG-01 The predisposing factors leading to the progress of the disease are traumas, change of blood coagulability, haemostasia (venous congestion) caused by varicose veins or body overweight. Typical symptoms Pains, sensation of weight, edema, accompanied by thrombosis complications (the most frequent among them being thrombophlebitis, i.e. veins inflammation). -
Page 41: Varicose Veins
ALMAG-01 microcirculation around the affected vein and the trophic ulcer results in an increased inflow of blood rich with structural elements and oxygen, as well as the outflow of the accumulated products of inflammation and carbon dioxide. The combination of the above eliminates the inflammatory processes and heals the trophic ulcer. -
Page 42: Maintenance
ALMAG-01 The procedures are carried out once a day if both legs are affected, and twice a day if one is affected. ALMAG is placed along the veins (see Fig. 23). IMPORTANT! The first emitter is placed closest to the foot, and the fourth one directly upon the knee fossa. -
Page 43: Acceptance Certificate
Date of production ____________________________ Stamp ____________________________________________ (signature of the person responsible for acceptance) ALMAG-01 Pulsed Electromagnetic Field Therapy Device is packed in compliance with the requirements specified in the design documentation. Date of packing __________________________ Packed by ______________________________ Stamp... -
Page 44: Manufacturer's Warranty
- the device has been damaged as a result of connecting it to a power line with improper features. Manufacturer’s address: Yelatma Instrument Making Enterprise, JSC (ELAMED) 25 Yanin St., Yelatma, Ryazan region 391351 Russia Tel./fax : +7 (4912) 503-023, +7 (49131) 2-04-57 e-mail: global@elamed.com... - Page 45 JSC «Yelatma Instrument Making Enterprise» Tel/fax: +7 (4912) 503-023, +7 (49131) 2-04-57 WARRANTY SHEET for repair (replacement) within warranty period of ALMAG-01 Pulsed Electromagnetic Field (PEMF) Therapy Device ТУ 9444-004-40279992-99 Manufacturing date_____________ No.__________________ Purchased _________________________________________ (to be filled in by the trading organization)
- Page 46 ALMAG-01 Operating Manual Page 46...
- Page 47 JSC «Yelatma Instrument Making Enterprise» Tel/fax: +7 (4912) 503-023, +7 (49131) 2-04-57 WARRANTY SHEET for repair (replacement) within warranty period of ALMAG-01 Pulsed Electromagnetic Field (PEMF) Therapy Device ТУ 9444-004-40279992-99 Manufacturing date_____________ No.__________________ Purchased _________________________________________ (to be filled in by the trading organization)
- Page 48 ALMAG-01 Operating Manual Page 48...
- Page 49 JSC «Yelatma Instrument Making Enterprise» Tel/fax: +7 (4912) 503-023, +7 (49131) 2-04-57 WARRANTY SHEET for repair (replacement) within warranty period of ALMAG-01 Pulsed Electromagnetic Field (PEMF) Therapy Device ТУ 9444-004-40279992-99 Manufacturing date_____________ No.__________________ Purchased _________________________________________ (to be filled in by the trading organization)
- Page 50 ALMAG-01 Operating Manual Page 50...
Need help?
Do you have a question about the ALMAG-01 and is the answer not in the manual?
Questions and answers
Do you have instructions available for the ALMAG+ in English, please?
The English instructions for the Elamed ALMAG-01 include the following:
1. Read the Operating Manual carefully before first use.
2. Use the device according to the instructions for proper treatment and effectiveness.
3. If giving the device to another person, also provide the Manual.
4. The device is intended for therapeutic treatment using a pulsed electromagnetic field.
5. It can be used by medical staff in healthcare facilities or by individuals at home.
6. ALMAG-01 models are made for different power standards, including 120V/60Hz for North America and 230V/50Hz for other regions.
7. Place the control unit on a flat surface with untwisted cables.
8. Check the device for damage before use and do not use it if any parts are damaged.
9. Protect the device from moisture, shock, and impact.
10. During cleaning, avoid getting moisture inside the control unit or emitters.
This answer is automatically generated